Farmasian teknologian ja biofarmasian laitos
Department of Pharmaceutics

Julkaisut 1996
Publications 1996

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Auriola S et al. Analysis of oligonucleotides by on-column transient capillary isotachophoresis and capillary electrophoresis in poly(ethylene glycol)-filled columns.
2 Hirvonen J et al. Transdermal delivery of peptides by iontophoresis.
3 Hirvonen J, Sutinen R. Transdermaalisissa lääkevalmisteissa käytettävät polymeerit lääkeaineen vapautumisen säätelyssä.
4 Hirvonen M-R et al. Streptomyces bacteria isolated from moldy houses induce the expression of inducible nitric oxide synthase and cause production of no, tumor necrosis factor and interleukin-6 in macrophage cell line.
5 Hirvonen M-R et al. Streptomyces-induced production of nitric oxide, tumor necrosis factor and interleukin-6 is not cytotoxic in raw264.7 macrophage cell line.
6 Jarho P et al. Modified ß-cyclodextrin (SBE7-ß-CyD) with viscous vehicle improves the ocular delivery and tolerability of pilocarpine prodrug in rabbits.
7 Jarho P et al. The effect of SBE7-ß-CD with viscous vehicle on ocular delivery of pilocarpine prodrug in rabbits.
8 Jarho P et al. Hydroxypropyl-ß-cyclodextrin increases aqueous solubility and stability of anandamide.
9 Jarho P et al. Increase in aqueous solubility, stability and in vitro corneal permeability of anandamide by hydroxypropyl-ß-cyclodextrin.
10 Jarho P et al. The effects of HP-ß-CD on aqueous solubility, stability and in vitro corneal penetration of anandamide.
11 Jarvinen T et al., inventor. Novel pilocarpine derivatives and process for their preparation.
12 Järvinen K. Silmälääkinnässä käytettävät polymeerit. Silmälamellit.
13 Järvinen T, Järvinen K. Prodrugs for improved ocular drug delivery.
14 Kirjavainen M et al. Interaction of liposomes with human skin in vitro - the influence of lipid composition and structure.
15 Lappalainen K et al. Effects of liposomal antisense oligonucleotides on mRNA and protein levels of the HPV 16 E7 oncogene.
16 Makkonen N et al. Different effects of three bisphosphonates on nitric oxide production by RAW 264 macrophage-like cells in vitro.
17 Munoz-Ruiz A, Paronen P. Time-dependent densification behaviour of cyclodextrins.
18 Munoz-Ruiz A, Paronen P. Effect of pre- and main compression level and rotary tablet press speed on tablet properties.
19 Munoz-Ruiz A et al. Evaluation of friction in double-sided tablet compression.
20 Mönkkönen J. Liposomit ja niiden lääkeellinen käyttö.
21 Ollikainen H et al. Liposomal targeting of Bcl-2 antisense oligonucleotides with enhanced stability into human myeloma cell lines.
22 Pate DW et al. Effects of topical anandamides on intraocular pressure in normotensive rabbits.
23 Raatikainen P et al. A comparison of three- and four-point beam bending tests using double-exposure holographic interferometry.
24 Raatikainen P et al. Evaluation of compressional characteristics of some excipients using ultrasonic measurement.
25 Saarinen-Savolainen P et al. Amphiphilic properties of pilocarpine prodrugs.
26 Selander KS et al. Calcitonin promotes osteoclast survival in vitro.
27 Selander KS et al. Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages.
28 Silvennoinen R et al. Holographic evaluation of bending and integrity of pharmaceutical powder beams.
29 Suhonen P. Pilokarpiinin silmäimeytymisen edistäminen aihiolääkkeiden avulla.
30 Suhonen P. Modification of Ocular Pilocarpine Delivery by Prodrug Derivatization: In Vitro and In Vivo Studies.
31 Suhonen P et al. Rate control of ocular pilocarpine delivery with bispilocarpic acid diesters.
32 Suhonen TM. Macroscopic and Molecular Biophysical Aspects of Percutaneous Penetration Enhancement.
33 Suihko E et al. Partial least squares (pls) analysis in prediction of contact angles for pharmaceutical materials.
34 Sutinen R. Controlled Release of Drugs from Silicone Based Devices. Effects of Hydrophilic and pH-adjusting Additives.
35 Sutinen R et al. Effect of cyclodextrin on the drug release from pH-controlled silicone microspheres.
36 Syrjänen K et al. HLA types in women with cervical human papillomavirus (HPV) lesions prospectively followed up for 10 years.
37 Urtti A. Ne fuusiot.
38 Urtti A. Oppia ikä kaikki.
39 Urtti AO et al., inventor. Peroral drug delivery system.
40 Villo M et al. Inhalaatioaerosolin ja moniannosjauheinhalaattorin käytön oppiminen.
41 Ylitalo R et al. Accumulation of bisphosphonates in the aorta and some other tissues of healthy and atherosclerotic rabbits.
42 Åkerman S et al. Muuntuvat polymeerimembraanit.
43 Åkerman S et al. Segregation of aflp markers in betula pendula (roth).

Farmasian teknologian ja biofarmasian laitos Department of Pharmaceutics
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008